Current Neuropharmacology · 2010 · 117 citations · 83 references
MedicineNeurosciencePharmacologyMetabolismNeurochemistryNeuropharmacologyCytochrome P450 EnzymesCytochrome P450-mediated MetabolismNeurochemical PharmacologyNeuronal MetabolismNeuroprotectionNeurotransmitter MetabolismCytochrome P450 OxidationMelatonin PharmacologyMelatonin PhysiologyMelatonin TreatmentNon-enzymatic AntioxidantsNon-enzymatic OxidationPineal Gland FunctionPineal Gland Physiology
The metabolism of melatonin in the central nervous system is of interest for several reasons. Melatonin enters the brain either via the pineal recess or by uptake from the blood. It has been assumed to be also formed in some brain areas. Neuroprotection by melatonin has been demonstrated in numerous model systems, and various attempts have been undertaken to counteract neurodegeneration by melatonin treatment. Several concurrent pathways lead to different products. Cytochrome P450 subforms have been demonstrated in the brain. They either demethylate melatonin to Nacetylserotonin, or produce 6-hydroxymelatonin, which is mostly sulfated already in the CNS. Melatonin is deacetylated, at least in pineal gland and retina, to 5-methoxytryptamine. N1-acetyl-N2-formyl-5-methoxykynuramine is formed by pyrrole-ring cleavage, by myeloperoxidase, indoleamine 2,3-dioxygenase and various non-enzymatic oxidants. Its product, N1-acetyl-5-methoxykynuramine, is of interest as a scavenger of reactive oxygen and nitrogen species, mitochondrial modulator, downregulator of cyclooxygenase-2, inhibitor of cyclooxygenase, neuronal and inducible NO synthases. Contrary to other nitrosated aromates, the nitrosated kynuramine metabolite, 3-acetamidomethyl-6-methoxycinnolinone, does not re-donate NO. Various other products are formed from melatonin and its metabolites by interaction with reactive oxygen and nitrogen species. The relative contribution of the various pathways to melatonin catabolism seems to be influenced by microglia activation, oxidative stress and brain levels of melatonin, which may be strongly changed in experiments on neuroprotection. Many of the melatonin metabolites, which may appear in elevated concentrations after melatonin administration, possess biological or pharmacological properties, including N-acetylserotonin, 5- methoxytryptamine and some of its derivatives, and especially the 5-methoxylated kynuramines. Keywords: Kynuramines, melatonin, 5-methoxytryptamine, N-acetylserotonin, reactive nitrogen species, reactive oxygen species, 6-sulfatoxymelatonin
83
Indoleamine 2,3-dioxygenase. Purification and some properties
Takeshi Shimizu, Shuji Nomiyama, Fusao Hirata et al. · Journal of Biological Chemistry · 1978 · 366 citations · Full text
Medical implications of melatonin: receptor-mediated and receptor-independent actions.
Rüssel J. Reiter, Dun‐Xian Tan, Lucien C. Manchester et al. · PubMed · 2007 · 334 citations
Juan C. Mayo, Rosa M. Sáinz, Dun‐Xian Tan et al. · Journal of Neuroimmunology · 2005 · 330 citations
Medicine, Pharmacology, Inflammation +11
In Vitro and in Vivo Formation of Two New Metabolites of Melatonin
Fusao Hirata, Osamu Hayaishi, Takashi Tokuyama et al. · Journal of Biological Chemistry · 1974 · 325 citations · Full text
METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450
Xiaochao Ma, Jeffrey R. Idle, Kristopher W. Krausz et al. · Drug Metabolism and Disposition · 2004 · 321 citations
Medicine, Biochemistry, Pharmacology +13